Trident Texofab clarifies on significant share price movement

Trident Texofab Ltd responded to BSE's inquiry regarding significant movement in its share price. The company stated that all material information and announcements, including disclosures under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and insider trading regulations, have been disclosed within the stipulated time. Trident Texofab confirmed that there is no pending information or announcement that could have a bearing on the company's share price movement. The company attributed the share price fluctuations purely to market conditions, over which it has no control or specific knowledge of the reasons.